MedTrace Logo

Physica CR and Physica PS Clinical Trial

NCT02766231 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2025-03-10

No results posted yet for this study

Summary

Type \& Design:

Post-market, international, multicentre Prospective, parallel groups, open-label, baseline controlled

Objectives:

1. Assessment of clinical, radiographic and patient-reported outcomes of Physica CR and PS designs
2. Incidence of adverse events and identification of possible risk factors for unsatisfactory results
3. Mid-term survivorship of the implants

Conditions

Interventions

DEVICE

Physica CR

Cruciate retaining total knee replacement

DEVICE

Physica PS

Posterior Stabilized total knee replacement

Sponsors & Collaborators

  • Limacorporate S.p.a

    lead INDUSTRY

Principal Investigators

  • Giuseppe Peretti, MD · I.R.C.C.S. Galeazzi (Milan, Italy)

Eligibility

Min Age
22 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • Belgium
  • Italy
  • Luxembourg

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02766231 on ClinicalTrials.gov